Acute Lung Injury Market 2027 By Therapy, End User and Geography | The Insight Partners

Acute Lung Injury Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy (Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, Others); End User (Hospitals, Clinics, Others.) and Geography

Report Code: TIPRE00015798 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Acute lung injury (ALI) is a life-threatening condition in critically unhealthy patients. In Acute lung injury disorder, acute inflammation occurs in the lung, which leads to the disruption of the lung endothelial and epithelial barriers. The alveolar-capillary membrane is composed of the microvascular endothelium, interstitium, and alveolar epithelium. ALI is diagnosed clinically based on the appearance of non-cardiogenic pulmonary odema and respiratory failure in a critically ill patient. Its incidence is normal; it is likely to exist outside the intensive care setting and therefore is a condition relevant to all clinicians.

MARKET DYNAMICS

The Acute Lung Injury market is growing due to the rise in geriatric population and technological advancement contributing in the growth of market. However, the low adoption rate of digital radiography is expected to hamper the growth of the global Acute Lung Injury market.

MARKET SCOPE

The "Acute Lung Injury Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Acute Lung Injury market with detailed market segmentation therapy, end user and geography. The Acute Lung Injury market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Acute Lung Injury market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Acute Lung Injury market is segmented on the basis of therapy and end user. Based on therapy, the market is segmented Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, and Others. On the basis of end user, the market segmented into Hospitals, Clinics, and Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Acute Lung Injury market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Acute Lung Injury market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Acute Lung Injury market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Acute Lung Injury market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Acute Lung Injury market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Acute Lung Injury market are anticipated to have lucrative growth opportunities in the future with the rising demand for Acute Lung Injury in the global market. Below mentioned is the list of few companies engaged in the Acute Lung Injury market.

The report also includes the profiles of key players in Acute Lung Injury market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Altor BioScience Corporation
  •  FirstString Research, Inc.
  •  GlaxoSmithKline Plc
  •  Forschung und Entwicklung GmbH
  •  Commence Bio, Inc.
  •  CompleGen, Inc.
  •  Histocell S.L.
  •  Stemedica Cell Technologies, Inc.
  •  Windtree Therapeutics, Inc.
  •  S-Evans Biosciences, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Acute Lung Injury Market - By Therapy
1.3.2 Acute Lung Injury Market - By End User
1.3.3 Acute Lung Injury Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ACUTE LUNG INJURY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ACUTE LUNG INJURY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ACUTE LUNG INJURY MARKET - GLOBAL MARKET ANALYSIS
6.1. ACUTE LUNG INJURY - GLOBAL MARKET OVERVIEW
6.2. ACUTE LUNG INJURY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ACUTE LUNG INJURY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. PHARMACOTHERAPY
7.3.1. Overview
7.3.2. Pharmacotherapy Market Forecast and Analysis
7.4. MECHANICAL VENTILATION
7.4.1. Overview
7.4.2. Mechanical Ventilation Market Forecast and Analysis
7.5. ADJUNCTIVE PROCEDURES
7.5.1. Overview
7.5.2. Adjunctive Procedures Market Forecast and Analysis
7.6. FLUID MANAGEMENT
7.6.1. Overview
7.6.2. Fluid Management Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ACUTE LUNG INJURY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS.
8.5.1. Overview
8.5.2. Others. Market Forecast and Analysis

9. ACUTE LUNG INJURY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Acute Lung Injury Market Overview
9.1.2 North America Acute Lung Injury Market Forecasts and Analysis
9.1.3 North America Acute Lung Injury Market Forecasts and Analysis - By Therapy
9.1.4 North America Acute Lung Injury Market Forecasts and Analysis - By End User
9.1.5 North America Acute Lung Injury Market Forecasts and Analysis - By Countries
9.1.5.1 United States Acute Lung Injury Market
9.1.5.1.1 United States Acute Lung Injury Market by Therapy
9.1.5.1.2 United States Acute Lung Injury Market by End User
9.1.5.2 Canada Acute Lung Injury Market
9.1.5.2.1 Canada Acute Lung Injury Market by Therapy
9.1.5.2.2 Canada Acute Lung Injury Market by End User
9.1.5.3 Mexico Acute Lung Injury Market
9.1.5.3.1 Mexico Acute Lung Injury Market by Therapy
9.1.5.3.2 Mexico Acute Lung Injury Market by End User
9.2. EUROPE
9.2.1 Europe Acute Lung Injury Market Overview
9.2.2 Europe Acute Lung Injury Market Forecasts and Analysis
9.2.3 Europe Acute Lung Injury Market Forecasts and Analysis - By Therapy
9.2.4 Europe Acute Lung Injury Market Forecasts and Analysis - By End User
9.2.5 Europe Acute Lung Injury Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Acute Lung Injury Market
9.2.5.1.1 Germany Acute Lung Injury Market by Therapy
9.2.5.1.2 Germany Acute Lung Injury Market by End User
9.2.5.2 France Acute Lung Injury Market
9.2.5.2.1 France Acute Lung Injury Market by Therapy
9.2.5.2.2 France Acute Lung Injury Market by End User
9.2.5.3 Italy Acute Lung Injury Market
9.2.5.3.1 Italy Acute Lung Injury Market by Therapy
9.2.5.3.2 Italy Acute Lung Injury Market by End User
9.2.5.4 Spain Acute Lung Injury Market
9.2.5.4.1 Spain Acute Lung Injury Market by Therapy
9.2.5.4.2 Spain Acute Lung Injury Market by End User
9.2.5.5 United Kingdom Acute Lung Injury Market
9.2.5.5.1 United Kingdom Acute Lung Injury Market by Therapy
9.2.5.5.2 United Kingdom Acute Lung Injury Market by End User
9.2.5.6 Rest of Europe Acute Lung Injury Market
9.2.5.6.1 Rest of Europe Acute Lung Injury Market by Therapy
9.2.5.6.2 Rest of Europe Acute Lung Injury Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Acute Lung Injury Market Overview
9.3.2 Asia-Pacific Acute Lung Injury Market Forecasts and Analysis
9.3.3 Asia-Pacific Acute Lung Injury Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Acute Lung Injury Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Acute Lung Injury Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Acute Lung Injury Market
9.3.5.1.1 Australia Acute Lung Injury Market by Therapy
9.3.5.1.2 Australia Acute Lung Injury Market by End User
9.3.5.2 China Acute Lung Injury Market
9.3.5.2.1 China Acute Lung Injury Market by Therapy
9.3.5.2.2 China Acute Lung Injury Market by End User
9.3.5.3 India Acute Lung Injury Market
9.3.5.3.1 India Acute Lung Injury Market by Therapy
9.3.5.3.2 India Acute Lung Injury Market by End User
9.3.5.4 Japan Acute Lung Injury Market
9.3.5.4.1 Japan Acute Lung Injury Market by Therapy
9.3.5.4.2 Japan Acute Lung Injury Market by End User
9.3.5.5 South Korea Acute Lung Injury Market
9.3.5.5.1 South Korea Acute Lung Injury Market by Therapy
9.3.5.5.2 South Korea Acute Lung Injury Market by End User
9.3.5.6 Rest of Asia-Pacific Acute Lung Injury Market
9.3.5.6.1 Rest of Asia-Pacific Acute Lung Injury Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Acute Lung Injury Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Acute Lung Injury Market Overview
9.4.2 Middle East and Africa Acute Lung Injury Market Forecasts and Analysis
9.4.3 Middle East and Africa Acute Lung Injury Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Acute Lung Injury Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Acute Lung Injury Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Acute Lung Injury Market
9.4.5.1.1 South Africa Acute Lung Injury Market by Therapy
9.4.5.1.2 South Africa Acute Lung Injury Market by End User
9.4.5.2 Saudi Arabia Acute Lung Injury Market
9.4.5.2.1 Saudi Arabia Acute Lung Injury Market by Therapy
9.4.5.2.2 Saudi Arabia Acute Lung Injury Market by End User
9.4.5.3 U.A.E Acute Lung Injury Market
9.4.5.3.1 U.A.E Acute Lung Injury Market by Therapy
9.4.5.3.2 U.A.E Acute Lung Injury Market by End User
9.4.5.4 Rest of Middle East and Africa Acute Lung Injury Market
9.4.5.4.1 Rest of Middle East and Africa Acute Lung Injury Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Acute Lung Injury Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Acute Lung Injury Market Overview
9.5.2 South and Central America Acute Lung Injury Market Forecasts and Analysis
9.5.3 South and Central America Acute Lung Injury Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Acute Lung Injury Market Forecasts and Analysis - By End User
9.5.5 South and Central America Acute Lung Injury Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Acute Lung Injury Market
9.5.5.1.1 Brazil Acute Lung Injury Market by Therapy
9.5.5.1.2 Brazil Acute Lung Injury Market by End User
9.5.5.2 Argentina Acute Lung Injury Market
9.5.5.2.1 Argentina Acute Lung Injury Market by Therapy
9.5.5.2.2 Argentina Acute Lung Injury Market by End User
9.5.5.3 Rest of South and Central America Acute Lung Injury Market
9.5.5.3.1 Rest of South and Central America Acute Lung Injury Market by Therapy
9.5.5.3.2 Rest of South and Central America Acute Lung Injury Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ACUTE LUNG INJURY MARKET, KEY COMPANY PROFILES
11.1. ALTOR BIOSCIENCE CORPORATION
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. FIRSTSTRING RESEARCH, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. FORSCHUNG UND ENTWICKLUNG GMBH
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. COMMENCE BIO, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. COMPLEGEN, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HISTOCELL S.L.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. STEMEDICA CELL TECHNOLOGIES, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. WINDTREE THERAPEUTICS, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. S-EVANS BIOSCIENCES, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Altor BioScience Corporation
2. FirstString Research, Inc.
3. GlaxoSmithKline Plc
4. Forschung und Entwicklung GmbH
5. Commence Bio, Inc.
6. CompleGen, Inc.
7. Histocell S.L.
8. Stemedica Cell Technologies, Inc.
9. Windtree Therapeutics, Inc.
10. S-Evans Biosciences, Inc.
TIPRE00015798
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking